{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T18:29:08Z","timestamp":1722536948288},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T00:00:00Z","timestamp":1367884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s40258-013-0030-4","type":"journal-article","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T08:27:55Z","timestamp":1367828875000},"page":"237-249","source":"Crossref","is-referenced-by-count":9,"title":["Implications of a Data-Driven Approach to Treatment with Growth Hormone in Children with Growth Hormone Deficiency and Turner Syndrome"],"prefix":"10.1007","volume":"11","author":[{"given":"Stefan","family":"Kaspers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Ranke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Wollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Roelants","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"Kleintjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,7]]},"reference":[{"issue":"5","key":"30_CR1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000322878","volume":"75","author":"P Bang","year":"2011","unstructured":"Bang P, Bjerknes R, Dahlgren J, et al. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone. Horm Res Paediatr. 2011;75(5):335\u201345.","journal-title":"Horm Res Paediatr"},{"issue":"5 Pt 2","key":"30_CR2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0022-3476(96)70011-2","volume":"128","author":"G Werther","year":"1996","unstructured":"Werther G. Growth hormone measurements versus auxology in treatment decisions: the Australian experience. J Pediatr. 1996;128(5 Pt 2):S47\u201351.","journal-title":"J Pediatr"},{"issue":"Suppl 3","key":"30_CR3","first-page":"613","volume":"16","author":"GA Werther","year":"2003","unstructured":"Werther GA, Wang M, Cowell CT. An auxology-based growth hormone program: update on the Australian experience. J Pediatr Endocrinol Metab. 2003;16(Suppl 3):613\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"30_CR4","doi-asserted-by":"crossref","unstructured":"Ranke MB, Lindberg A, KIGS International Board. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables. J Clin Endocrinol Metab. 2010;95(3):1229\u201337.","DOI":"10.1210\/jc.2009-1471"},{"issue":"2","key":"30_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2012.04420.x","volume":"77","author":"P Bang","year":"2012","unstructured":"Bang P, Ahmed SF, Argente J, Backeljauw P, Bettendorf M, Bona G, Coutant R, Rosenfeld RG, Walenkamp MJ, Savage MO. Identification and management of poor response to growth-promoting therapy in children with short stature. Clin Endocrinol. 2012;77(2):169\u201381.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"30_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000339468","volume":"78","author":"MB Ranke","year":"2012","unstructured":"Ranke MB, Lindberg A, Brosz M, Kaspers S, Loftus J, Wollmann H, et al. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner syndrome. Horm Res Paediatr. 2012;78(1):8\u201317.","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"30_CR7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jc.2007-1581","volume":"93","author":"B Bakker","year":"2008","unstructured":"Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children. J Clin Endocrinol Metab. 2008;93(2):352\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"30_CR8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","volume":"84","author":"MB Ranke","year":"1999","unstructured":"Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, et al. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab. 1999;84(4):1174\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"30_CR9","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1210\/jcem.85.11.6976","volume":"85","author":"MB Ranke","year":"2000","unstructured":"Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, et al. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. J Clin Endocrinol Metab. 2000;85(11):4212\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"30_CR10","unstructured":"Pfizer Limited. Summary of Product Characteristics, Date of revision of the text: March 2012, electronic Medicines Compendium (eMC). http:\/\/www.medicines.org.uk . Accessed Dec 2012."},{"issue":"1","key":"30_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2008.08.001","volume":"19","author":"MB Ranke","year":"2009","unstructured":"Ranke MB, Lindberg A. Predicting growth in response to growth hormone treatment. Growth Horm IGF Res. 2009;19(1):1\u201311.","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"30_CR12","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1210\/jc.2005-2284","volume":"91","author":"EO Reiter","year":"2006","unstructured":"Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab. 2006;91(6):2047\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"30_CR13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3111\/13696998.2011.597808","volume":"14","author":"A Golay","year":"2011","unstructured":"Golay A. Pharmacoeconomic aspects of poor adherence: can better adherence reduce healthcare costs? J Med Econ. 2011;14(5):594\u2013608.","journal-title":"J Med Econ."},{"issue":"8","key":"30_CR14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/00005650-199808000-00004","volume":"36","author":"DL Roter","year":"1998","unstructured":"Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36(8):1138\u201361.","journal-title":"Med Care"},{"key":"30_CR15","unstructured":"National Institute for Health and Clinical Excellence (NICE). Human growth hormone (somatropin) for the treatment of growth failure in children (review of NICE technology appraisal guidance 42), Technology Appraisal 188, 2010."},{"key":"30_CR16","unstructured":"Department of Health and Aging, Australian Government. Guidelines for the Pharmaceutical Benefits Scheme Growth Hormone Program. http:\/\/www.health.gov.au\/hgh . Accessed Sep 2010."},{"issue":"4","key":"30_CR17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","volume":"143","author":"TA Wilson","year":"2003","unstructured":"Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P, Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr. 2003;143(4):415\u201321.","journal-title":"J Pediatr"},{"issue":"18","key":"30_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6180","volume":"6","author":"J Bryant","year":"2002","unstructured":"Bryant J, Cave C, Mihaylova B, et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess. 2002;6(18):1\u2013168.","journal-title":"Health Technol Assess"},{"key":"30_CR19","doi-asserted-by":"crossref","unstructured":"Takeda A, Cooper K, Bird A, et al. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health Technol Assess. 2010;14(42):1\u2013209. iii\u2013iv.","DOI":"10.3310\/hta14420"},{"issue":"2","key":"30_CR20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1185\/030079906X80503","volume":"22","author":"AV Joshi","year":"2006","unstructured":"Joshi AV, Munro V, Russell MW. Cost-utility of somatropin (rDNA origin) in the treatment of growth hormone deficiency in children. Curr Med Res Opin. 2006;22(2):351\u20137.","journal-title":"Curr Med Res Opin"},{"key":"30_CR21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/adc.2006.114249","volume":"93","author":"RR Kapoor","year":"2008","unstructured":"Kapoor RR, Burke SA, Sparrow SE, et al. Monitoring of concordance in growth hormone therapy. Arch Dis Child. 2008;93:147\u20138.","journal-title":"Arch Dis Child"},{"key":"30_CR22","doi-asserted-by":"crossref","first-page":"e16223","DOI":"10.1371\/journal.pone.0016223","volume":"6","author":"WS Cutfield","year":"2011","unstructured":"Cutfield WS, Derraik JG, Gunn AJ, et al. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One. 2011;6:e16223.","journal-title":"PLoS One"},{"key":"30_CR23","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1210\/jc.2003-030600","volume":"88","author":"MB Ranke","year":"2003","unstructured":"Ranke MB, Lindberg A, Martin DD, et al. The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose. J Clin Endocrinol Metab. 2003;88:4748\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"30_CR24","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1210\/jc.2004-1051","volume":"90","author":"MB Ranke","year":"2005","unstructured":"Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0\u20133 years) with idiopathic GH deficiency: analysis of data from KIGS. J Clin Endocrinol Metab. 2005;90:1966\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"30_CR25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jc.2002-020867","volume":"88","author":"MB Ranke","year":"2003","unstructured":"Ranke MB, Lindberg A, Cowell CT, et al. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J Clin Endocrinol Metab. 2003;88:125\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"30_CR26","first-page":"34","volume":"8","author":"M Ranke","year":"1992","unstructured":"Ranke M, Guilbaud O. Growth hormone levels in response to stimulation tests and responsiveness to growth hormone in children with growth hormone deficiency and idiopathic short stature. Kabi Pharm Int Growth Study. 1992;8(1):34\u201341.","journal-title":"Kabi Pharm Int Growth Study"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-013-0030-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-013-0030-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-013-0030-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T18:12:08Z","timestamp":1551204728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-013-0030-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s40258-013-0030-4","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,7]]}}}